PARIS: French pharmaceuticals giant Sanofi, which was beaten by competitors to a Covid-19 vaccine, said on Monday it would spend 400 million euros ($475 million) on building a new plant that can produce several vaccines at once.
The high-tech factory will be located in Singapore and will be operational in the first quarter of 2026, the company said, adding that construction would start this summer.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.